Skip to main content
. 2022 Jul 6;8(2):e002270. doi: 10.1136/rmdopen-2022-002270

Table 3.

Laboratory data

Variable, median (IQR) Patients with SpA Controls P value
CRP (mg/L) 6.45 (1.5-19.9) 4.1 (1.45–7.25) 0.001
Fasting blood sugar (mmo/L) 4.93 (4.55–5.1) 4.88 (4.51–5.08) 0.639
Creatinine (µmol/L) 63 (58.5–74) 63 (55–70) 0.342
Total cholesterol (mmo/L) 3.66 (3.18-4.28) 3.60 (3.46–4.23) 0.904
Triglycerides (mmo/L) 0.84 (0.79–1.15) 0.92 (0.78–1.06) 0.946
C-LDL (mmo/L) 2.17 (1.78–2.6) 2.1 (1.7–2.5) 0.943
C-HDL (mmo/L) 1.08 (0.92–1.2) 1.16 (0.99–1.31) 0.052
CT/C-HDL 3.48 (2.95–3.97) 3.21 (2.69–3.77) 0.248
C-LDL/C-HDL 1.99 (1.54–2.48) 1.9 (1.43–2.31) 0.339

CRP, C reactive protein; CT, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.